Oramed Pharmaceuticals
ORMP
ORMP
27 hedge funds and large institutions have $3.4M invested in Oramed Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.58% more ownership
Funds ownership: 2.06% → 2.64% (+0.58%)
68% less call options, than puts
Call options by funds: $9K | Put options by funds: $28K
Holders
27
Holding in Top 10
–
Calls
$9K
Puts
$28K
Top Buyers
| 1 | +$191K | |
| 2 | +$143K | |
| 3 | +$135K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$116K |
| 5 |
Renaissance Technologies
New York
|
+$94.6K |
Top Sellers
| 1 | -$38.5K | |
| 2 | -$3K | |
| 3 | -$2.59K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |